组织工程与重建外科杂志2025，Vol.21Issue(5)：419-424,6.DOI:10.3969/j.issn.1673-0364.2025.05.001
理念与技术:重度上睑下垂治疗策略
Principle and technology:Treatment strategies for severe blepharoptosis
摘要
Abstract
The simultaneous reconstruction of function and aesthetics in severe blepharoptosis has long been a clinical difficulty and challenge.The frontalis muscle and levator palpebrae superioris muscle(LPS)are the two major sources of force for upper eyelid elevation.Centering on these two power sources,in the field of severe blepharoptosis treatment,surgical procedures such as frontalis muscle and its fascia suspension,frontalis muscle suspension with materials(synthetic or autologous/allogeneic materials),levator aponeurosis-Müller's muscle complex advancement and shortening(or combined with partial tarsectomy),and conjoint fascial sheath(CFS)surgery have long been adopted by clinicians.However,there have always been controversies regarding their respective advantages and disadvantages as well as their indications.Different surgeons often make different choices based on their varying clinical experience and perspectives.It is precisely this divergence in the logic of different choices that leads to inconsistent decisions in specific clinical treatments,and results in uncertain and unstable treatment outcomes.To make the optimal choice and achieve the best results according to the characteristics of each clinical case,it is essential to understand the pathogenesis,be familiar with the anatomical physiology,clarify the characteristics and target indications of various surgical procedures,optimize the technical process of each procedure,and sort out the logic for surgical procedure selection.关键词
上睑下垂/额肌/上睑提肌/联合筋膜鞘/浮桥技术/人工材料/悬吊术Key words
Blepharoptosis/Frontalis muscle/Levator palpebrae superioris muscle/Combined fascial sheath(CFS)/Bridge technique/Synthetic materials/Suspension surgery分类
医药卫生引用本文复制引用
杨锋,沈一蕊,杨军..理念与技术:重度上睑下垂治疗策略[J].组织工程与重建外科杂志,2025,21(5):419-424,6.基金项目
国家自然科学基金(81871576) （81871576）
国家自然科学基金青年项目(82102354,82402938) （82102354,82402938）
上海市自然科学基金(19ZR1430100) （19ZR1430100）
上海市科学技术委员会临床医学研究中心项目(22MC1940300). （22MC1940300）
